Potential Phytotherapy of DSS-Induced Colitis: Ameliorating Reactive Oxygen Species-Mediated Necroptosis and Gut Dysbiosis with a New Crataegus pinnatifida Bunge Variety-Daehong
- Antioxidants (Basel). 2024 Mar 12;13(3):340. doi: 10.3390/antiox13030340.
- 1. KM Science Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Republic of Korea.
- 2. College of Pharmacy, Chungbuk National University, Cheongju 28160, Republic of Korea.
- 3. Department of Future Convergence Industry, Bio Health Industry Team, Sejong Technopark, Sejong-si 30141, Republic of Korea.
- 4. KM Convergence Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Republic of Korea.
- 5. Solwon Biotechnology, 3899, Sejong-ro, Jeonui-myeon, Sejong-si 30005, Republic of Korea.
Developing new plant varieties plays a crucial role in competitiveness in the agricultural and food industries and enhancing food security. Daehong (DH) is a new variety of Crataegus pinnatifida Bunge (CP); however, its physiological functions and potential as a nutraceutical ingredient remain unknown. Here, the efficacy of DH on inflammatory bowel disease (IBD) was investigated using dextran sulfate sodium (DSS)-induced colitis mice, and its relative pharmacological effects were analyzed against CP. DH improved colitis-induced weight loss, colon shortening, and inflammatory responses and reduced intestinal permeability. The Reactive Oxygen Species (ROS)-mediated necroptotic signal that triggers enterocyte cell death in DSS-induced colitis was effectively controlled by DH, attributed to epicatechin. DSS-induced gut dysbiosis was recovered into a healthy gut microbiome environment by DH, increasing beneficial bacteria, like Akkermansia muciniphila, and changing harmful bacteria, including Bacteroides vulgatus and Peptostreptococcaceae. DH shows potential as a dietary or pharmaceutical ingredient to promote gut health and to prevent and treat IBD.